{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:55:50Z","timestamp":1794322550622,"version":"4.9.0"},"reference-count":139,"publisher":"Bentham Science Publishers Ltd.","issue":"24","funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior - Brasil","doi-asserted-by":"publisher","award":["01"],"award-info":[{"award-number":["01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308590\/2017-1"],"award-info":[{"award-number":["308590\/2017-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2020,11,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Methicillin-resistant and vancomycin-resistant Staphylococcus aureus are\npathogens causing severe infectious diseases that pose real public health threats problems worldwide. In\nS. aureus, the most efficient multidrug-resistant system is the NorA efflux pump. For this reason, it is\ncritical to identify efflux pump inhibitors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>In this paper, we present an update of the new natural and synthetic compounds that act as\nmodulators of antibiotic resistance through the inhibition of the S. aureus NorA efflux pump.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Several classes of compounds capable of restoring the antibiotic activity have been identified\nagainst resistant-S. aureus strains, acting as NorA efflux pump inhibitors. The most promising classes of\ncompounds were quinolines, indoles, pyridines, phenols, and sulfur-containing heterocycles. However,\nthe substantial degree structural diversity of these compounds makes it difficult to establish good structure-\nactivity correlations that allow the design of compounds with more promising activities and properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Despite substantial efforts put forth in the search for new antibiotic adjuvants that act as\nefflux pump inhibitors, and despite several promising results, there are currently no efflux pump inhibitors\nauthorized for human or veterinary use, or in clinical trials. Unfortunately, it appears that infection\ncontrol strategies have remained the same since the discovery of penicillin, and that most efforts remain\nfocused on discovering new classes of antibiotics, rather than trying to prolong the life of available antibiotics,\nand simultaneously fighting mechanisms of bacterial resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1568026620666200704135837","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T14:06:52Z","timestamp":1593871612000},"page":"2168-2185","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["An Update on Staphylococcus aureus NorA Efflux Pump Inhibitors"],"prefix":"10.2174","volume":"20","author":[{"given":"Kadja Luana Chagas","family":"Monteiro","sequence":"first","affiliation":[{"name":"Institute of Chemistry and Biotechnology, Federal University of Alagoas, Maceio, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Mendon\u00e7a","family":"de Aquino","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Biotechnology, Federal University of Alagoas, Maceio, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jaime B.","family":"Mendon\u00e7a Junior","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, State University of Paraiba, Laboratory of Synthesis and Drug Delivery, Joao Pessoa, PB, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41559-019-0854-x","volume":"3","author":"Brockhurst M.A.","year":"2019","unstructured":"Brockhurst M.A.; Harrison F.; Veening J.W.; Harrison E.; Blackwell G.; Iqbal Z.; Maclean C.; Assessing evolutionary risks of resistance for new antimicrobial therapies. Nat Ecol Evol 2019,3(4),515-517","journal-title":"Nat Ecol Evol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/infdis\/jiz134","volume":"220","author":"Cattoir V.","year":"2019","unstructured":"Cattoir V.; Felden B.; Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges. J Infect Dis 2019,220(3),350-360","journal-title":"J Infect Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/1568026618666180206095224","volume":"18","author":"Pontes D.S.","year":"2018","unstructured":"Pontes D.S.; de Araujo R.S.A.; Dantas N.; Scotti L.; Scotti M.T.; de Moura R.O.; Mendon\u00e7a-Junior F.J.B.; Genetic mechanisms of antibiotic resistance and the role of antibiotic adjuvants. Curr Top Med Chem 2018,18(1),42-74","journal-title":"Curr Top Med Chem"},{"key":"ref=4","year":"2014","unstructured":"Antimicrobial Resistance: Global Report on Surveillance 2014 World Health Organization (WHO)2014","journal-title":"Antimicrobial Resistance: Global Report on Surveillance 2014"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1057\/s41599-019-0251-8","volume":"5","author":"Landecker H.","year":"2019","unstructured":"Landecker H.; Antimicrobials before antibiotics: war, peace, and disinfectants. Palgrave Commun 2019,5,45","journal-title":"Palgrave Commun"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4315\/0362-028X.JFP-18-373","volume":"82","author":"Donaghy J.A.","unstructured":"Donaghy J.A.; Jagadeesan B.; Goodburn K.; Relationship of\nsanitizers, disinfectants, and cleaning agents with antimicrobial\nresistance. J Food Protec ,82(5),889-902","journal-title":"J Food Protec"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/cmdc.201900688.","volume":"15","author":"da Cruz R.M.D.","year":"2020","unstructured":"da Cruz R.M.D.; Zelli R.; Benshain S.; da Cruz R.M.D.; Siqueira\u2010J\u00fanior J.P.; D\u00e9cout J-L.; Mingeot\u2010Leclercq M-P.; Mendon\u00e7a-Junior F.J.B.; Synthesis and evaluation of 2\u2010aminothiophene derivatives as Staphylococcus aureus efflux pump inhibitors. ChemMedChem 2020,15(8),716-725","journal-title":"ChemMedChem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1021\/jm201446h","volume":"55","author":"Sabatini S.","year":"2012","unstructured":"Sabatini S.; Gosetto F.; Serritella S.; Manfroni G.; Tabarrini O.; Iraci N.; Brincat J.P.; Carosati E.; Villarini M.; Kaatz G.W.; Cecchetti V.; Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors. J Med Chem 2012,55(7),3568-3572","journal-title":"J Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","volume":"16","author":"Du D.","year":"2018","unstructured":"Du D.; Wang-Kan X.; Neuberger A.; Van Veen H.W.; Pos K.M.; Piddock L.J.V.; Luisi B.F.; Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol 2018,16,523-539","journal-title":"Nat Rev Microbiol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874285801307010059","volume":"7","author":"Costa S.S.","year":"2013","unstructured":"Costa S.S.; Viveiros M.; Amaral L.; Couto I.; Multidrug efflux\npumps in Staphylococcus aureus: An update. Open Microbiol J 2013,7(Suppl. 1-M5),59-71","journal-title":"Open Microbiol J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/jac\/dks232","volume":"67","author":"Kalia N.P.","year":"2012","unstructured":"Kalia N.P.; Mahajan P.; Mehra R.; Nargotra A.; Sharma J.P.; Koul S.; Khan I.A.; Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus. J Antimicrob Chemother 2012,67(10),2401-2408","journal-title":"J Antimicrob Chemother"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/antibiotics2010028","volume":"2","author":"Handzlik J.","year":"2013","unstructured":"Handzlik J.; Matys A.; Kie\u0107-Kononowicz K.; Recent advances in multi-drug resistance (mdr) efflux pump inhibitors of gram-positive bacteria s. aureus. Antibiotics (Basel) 2013,2(1),28-45","journal-title":"Antibiotics (Basel)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2147\/IDR.S228089","volume":"13","author":"Abdi S.N.","year":"2020","unstructured":"Abdi S.N.; Ghotaslou R.; Ganbarov K.; Mobed A.; Tanomand A.; Yousefi M.; Asgharzadeh M.; Kafil H.S.; Acinetobacter baumannii efflux pumps and antibiotic resistance. Infect Drug Resist 2020,13,423-434","journal-title":"Infect Drug Resist"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ddtec.2006.06.011","volume":"3","author":"Poole K.","year":"2006","unstructured":"Poole K.; Lomovskaya O.; Can efflux inhibitors really counter resistance? Drug Discov Today 2006,3,145-152","journal-title":"Drug Discov Today"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S1676-24442007000600005","volume":"43","author":"Mahamoud A.","year":"2007","unstructured":"Mahamoud A.; Chevalier J.; Alibert-Franco S.; Kern W.V.; Pages J.M.; Antibiotic efflux pumps in Gram-negative bacteria: The inhibitor response strategy. J. Antimicrob. Chemother, 2007, 59, 1223-1229. Staphylococcus aureus: visiting a strain of clinical importance. J Bras Patol Med Lab 2007,43(6),413-423","journal-title":"J Bras Patol Med Lab"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S1676-24442007000600005","volume":"43","author":"dos Santos A.L.","year":"2007","unstructured":"dos Santos A.L.; Santos D.O.; de Freitas C.C.; Ferreira B.L.A.; Afonso I.F.; Rodrigues C.R.; Castro H.C.; Staphylococcus aureus: visiting a strain of clinical importance. J Bras Patol Med Lab 2007,43(6),413-423","journal-title":"J Bras Patol Med Lab"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5739247","volume":"2019","author":"Kadariya J.","year":"2019","unstructured":"Kadariya J.; Thapaliya D.; Bhatta S.; Mahatara R.L.; Bempah S.; Dhakal N.; Smith T.C.; Multidrug-resistant staphylococcus aureus colonization in healthy adults is more common in bhutanese refugees in nepal than those resettled in ohio. BioMed Res Int 2019,2019","journal-title":"BioMed Res Int"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2475067","volume":"\u2022","author":"Santajit S.","year":"2016","unstructured":"Santajit S.; Indrawattana N.; Mechanisms of antimicrobial resistance in ESKAPE pathogens. BioMed Res Int 2016,\u2022","journal-title":"BioMed Res Int"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1128\/AAC.02574-14","volume":"58","author":"Roch M.","year":"2014","unstructured":"Roch M.; Clair P.; Renzoni A.; Reverdy M.E.; Dauwalder O.; Bes M.; Martra A.; Freydi\u00e8re A.M.; Laurent F.; Reix P.; Dumitrescu O.; Vandenesch F.; Exposure of Staphylococcus aureus to subinhibitory concentrations of \u03b2-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2014,58(9),5306-5314","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3201\/eid1506.081312","volume":"15","author":"Finks J.","year":"2009","unstructured":"Finks J.; Wells E.; Dyke T.L.; Husain N.; Plizga L.; Heddurshetti R.; Wilkins M.; Rudrik J.; Hageman J.; Patel J.; Miller C.; Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg Infect Dis 2009,15(6),943-945","journal-title":"Emerg Infect Dis"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8321834","volume":"2019","author":"Garoy E.Y.","year":"2019","unstructured":"Garoy E.Y.; Gebreab Y.B.; Achila O.O.; Tekeste D.G.; Kesete R.; Ghirmay R.; Kiflay R.; Tesfu T.; Methicillin-resistant staphylococcus aureus (mrsa): prevalence and antimicrobial sensitivity pattern among patients-a multicenter study in asmara, eritrea. Can J Infect Dis Med Microbiol 2019,2019","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","volume":"358","author":"Tsiodras S.","year":"2001","unstructured":"Tsiodras S.; Gold H.S.; Sakoulas G.; Eliopoulos G.M.; Wennersten C.; Venkataraman L.; Moellering R.C.; Ferraro M.J.; Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001,358(9277),207-208","journal-title":"Lancet"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"429.e1","DOI":"10.1016\/j.cmi.2017.07.028","volume":"24","author":"Werth B.J.","year":"2018","unstructured":"Werth B.J.; Jain R.; Hahn A.; Cummings L.; Weaver T.; Waalkes A.; Sengupta D.; Salipante S.J.; Rakita R.M.; Butler-Wu S.M.; Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen. Clin Microbiol Infect 2018,24(4),429.e1-429.e5","journal-title":"Clin Microbiol Infect"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/ijerph120201487","volume":"12","author":"Andersen J.L.","year":"2015","unstructured":"Andersen J.L.; He G-X.; Kakarla P.; K c, R.; Kumar, S.; Lakra, W.S.; Mukherjee, M.M.; Ranaweera, I.; Shrestha, U.; Tran, T.; Varela, M.F. Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health 2015,12(2),1487-1547","journal-title":"Int J Environ Res Public Health"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.3390\/ijms13044484","volume":"13","author":"Kumar S.","year":"2012","unstructured":"Kumar S.; Varela M.F.; Biochemistry of bacterial multidrug efflux pumps. Int J Mol Sci 2012,13(4),4484-4495","journal-title":"Int J Mol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2217\/fmb.11.156","volume":"7","author":"Otto M.","year":"2012","unstructured":"Otto M.; Methicillin-resistant Staphylococcus aureus infection is associated with increased mortality. Future Microbiol 2012,7(2),189-191","journal-title":"Future Microbiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/jam.13258","volume":"121","author":"Costa L.M.","year":"2016","unstructured":"Costa L.M.; de Macedo E.V.; Oliveira F.A.; Ferreira J.H.; Gutierrez S.J.; Pel\u00e1ez W.J.; Lima F.C.; de Siqueira J\u00fanior J.P.; Coutinho H.D.; Kaatz G.W.; de Freitas R.M.; Barreto H.M.; Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins. J Appl Microbiol 2016,121(5),1312-1322","journal-title":"J Appl Microbiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2147\/IDR.S201124","volume":"12","author":"Abd El-Baky R.M.","year":"2019","unstructured":"Abd El-Baky R.M.; Sandle T.; John J.; Abuo-Rahma G.E.A.; Hetta H.F.; A novel mechanism of action of ketoconazole: inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus. Infect Drug Resist 2019,12,1703-1718","journal-title":"Infect Drug Resist"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/jac\/dkg224","volume":"51","author":"Van Bambeke F.","year":"2003","unstructured":"Van Bambeke F.; Glupczynski Y.; Pl\u00e9siat P.; Pech\u00e8re J.C.; Tulkens P.M.; Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother 2003,51(5),1055-1065","journal-title":"J Antimicrob Chemother"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/dkg050","volume":"51","author":"Webber M.A.","year":"2003","unstructured":"Webber M.A.; Piddock L.J.V.; The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003,51(1),9-11","journal-title":"J Antimicrob Chemother"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1128\/AAC.00580-10","volume":"54","author":"Floyd J.L.","year":"2010","unstructured":"Floyd J.L.; Smith K.P.; Kumar S.H.; Floyd J.T.; Varela M.F.; LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob Agents Chemother 2010,54(12),5406-5412","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gene.2012.02.008","volume":"498","author":"Ogawa W.","year":"2012","unstructured":"Ogawa W.; Onishi M.; Ni R.; Tsuchiya T.; Kuroda T.; Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae. Gene 2012,498(2),177-182","journal-title":"Gene"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1073\/pnas.93.8.3630","volume":"93","author":"Paulsen I.T.","year":"1996","unstructured":"Paulsen I.T.; Brown M.H.; Littlejohn T.G.; Mitchell B.A.; Skurray R.A.; Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci USA 1996,93(8),3630-3635","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0966-842X(00)01920-X","volume":"9","author":"Borges-Walmsley M.I.","year":"2001","unstructured":"Borges-Walmsley M.I.; Walmsley A.R.; The structure and function of drug pumps. Trends Microbiol 2001,9(2),71-79","journal-title":"Trends Microbiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/bj20020957","volume":"376","author":"Borges-Walmsley M.I.","year":"2003","unstructured":"Borges-Walmsley M.I.; McKeegan K.S.; Walmsley A.R.; Structure and function of efflux pumps that confer resistance to drugs. Biochem J 2003,376(Pt 2),313-338","journal-title":"Biochem J"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5604\/17322693.937011","volume":"65","author":"Jarmu\u0142a A.","year":"2011","unstructured":"Jarmu\u0142a A.; Ob\u0142\u0105k E.; Wawrzycka D.; Gutowicz J.; [Effluxmediated\nantimicrobial multidrug resistance]. Postepy Hig Med Dosw 2011,65,216-227","journal-title":"Postepy Hig Med Dosw"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tibs.2013.01.003","volume":"38","author":"Yan N.","year":"2013","unstructured":"Yan N.; Structural advances for the major facilitator superfamily (MFS) transporters. Trends Biochem Sci 2013,38(3),151-159","journal-title":"Trends Biochem Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/35085077","volume":"2","author":"Kaback H.R.","year":"2001","unstructured":"Kaback H.R.; Sahin-T\u00f3th M.; Weinglass A.B.; The kamikaze approach to membrane transport. Nat Rev Mol Cell Biol 2001,2(8),610-620","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbi.2017.12.009","volume":"280","author":"Dantas N.","year":"2018","unstructured":"Dantas N.; de Aquino T.M.; de Ara\u00fajo-J\u00fanior J.X.; da Silva-J\u00fanior E.; Gomes E.A.; Gomes A.A.S.; Siqueira-J\u00fanior J.P.; Mendon\u00e7a Junior, F.J.B.; Aminoguanidine hydrazones (AGH\u2019s) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump. Chem Biol Interact 2018,280,8-14","journal-title":"Chem Biol Interact"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1128\/AAC.37.1.128","volume":"37","author":"Neyfakh A.A.","year":"1993","unstructured":"Neyfakh A.A.; Borsch C.M.; Kaatz G.W.; Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob Agents Chemother 1993,37(1),128-129","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1128\/AAC.39.12.2650","volume":"39","author":"Kaatz G.W.","year":"1995","unstructured":"Kaatz G.W.; Seo S.M.; Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1995,39(12),2650-2655","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=42","first-page":"247","volume":"3","author":"Lewis K.","year":"2001","unstructured":"Lewis K.; In search of natural substrates and inhibitors of MDR pumps. J Mol Microbiol Biotechnol 2001,3(2),247-254","journal-title":"J Mol Microbiol Biotechnol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.phytochem.2006.10.001","volume":"68","author":"Smith E.C.","year":"2007","unstructured":"Smith E.C.; Williamson E.M.; Wareham N.; Kaatz G.W.; Gibbons S.; Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana. Phytochemistry 2007,68(2),210-217","journal-title":"Phytochemistry"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.2174\/092986711796150469","volume":"18","author":"Pag\u00e8s J.M.","year":"2011","unstructured":"Pag\u00e8s J.M.; Amaral L.; Fanning S.; An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria. Curr Med Chem 2011,18(19),2969-2980","journal-title":"Curr Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/med.21591","volume":"39","author":"Lamut A.","year":"2019","unstructured":"Lamut A.; Peterlin Ma\u0161i\u010d L.; Kikelj D.; Toma\u0161i\u010d T.; Efflux pump inhibitors of clinically relevant multidrug resistant bacteria. Med Res Rev 2019,39(6),2460-2504","journal-title":"Med Res Rev"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/AAC.43.10.2404","volume":"43","author":"Markham P.N.","year":"1999","unstructured":"Markham P.N.; Westhaus E.; Klyachko K.; Johnson M.E.; Neyfakh A.A.; Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob Agents Chemother 1999,43(10),2404-2408","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=47","first-page":"843","volume":"16","author":"Schindler B.D.","year":"1968","unstructured":"Schindler B.D.; Jacinto P.; Kaatz G.W.; Inhibition of drug efflux pumps in staphylococcus aureus: current status of potentiating existing antibiotics. Chemother 1968,16,843-846","journal-title":"Chemother"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3389\/fmicb.2015.00660","volume":"6","author":"Dreier J.","year":"2015","unstructured":"Dreier J.; Ruggerone P.; Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa. Front Microbiol 2015,6,660","journal-title":"Front Microbiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1128\/AAC.41.12.2733","volume":"41","author":"Kaatz G.W.","year":"1997","unstructured":"Kaatz G.W.; Seo S.M.; Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 1997,41(12),2733-2737","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/jac\/dkl460","volume":"59","author":"Stavri M.","year":"2007","unstructured":"Stavri M.; Piddock L.J.V.; Gibbons S.; Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 2007,59(6),1247-1260","journal-title":"J Antimicrob Chemother"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1039\/c2np20035j","volume":"29","author":"Abreu A.C.","year":"2012","unstructured":"Abreu A.C.; McBain A.J.; Sim\u00f5es M.; Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep 2012,29(9),1007-1021","journal-title":"Nat Prod Rep"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1039\/b212695h","volume":"21","author":"Gibbons S.","year":"2004","unstructured":"Gibbons S.; Anti-staphylococcal plant natural products. Nat Prod Rep 2004,21(2),263-277","journal-title":"Nat Prod Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/cmdc.201000006","volume":"5","author":"Zhang L.","year":"2010","unstructured":"Zhang L.; Ma S.; Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump. ChemMedChem 2010,5(6),811-822","journal-title":"ChemMedChem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jac\/dkg044","volume":"51","author":"Gibbons S.","year":"2003","unstructured":"Gibbons S.; Oluwatuyi M.; Kaatz G.W.; A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother 2003,51(1),13-17","journal-title":"J Antimicrob Chemother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.ejmech.2008.01.042","volume":"43","author":"German N.","year":"2008","unstructured":"German N.; Wei P.; Kaatz G.W.; Kerns R.J.; Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps. Eur J Med Chem 2008,43(11),2453-2463","journal-title":"Eur J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1021\/jm950558v","volume":"39","author":"Cecchetti V.","year":"1996","unstructured":"Cecchetti V.; Fravolini A.; Lorenzini M.C.; Tabarrini O.; Terni P.; Xin T.; Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones. J Med Chem 1996,39(2),436-445","journal-title":"J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1021\/jm1003304","volume":"53","author":"Pieroni M.","year":"2010","unstructured":"Pieroni M.; Dimovska M.; Brincat J.P.; Sabatini S.; Carosati E.; Massari S.; Kaatz G.W.; Fravolini A.; From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps. J Med Chem 2010,53(11),4466-4480","journal-title":"J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/cmdc.201200551","volume":"8","author":"Dol\u00e9ans-Jordheim A.","year":"2013","unstructured":"Dol\u00e9ans-Jordheim A.; Veron J.B.; Fendrich O.; Bergeron E.; Montagut-Romans A.; Wong Y.S.; Furdui B.; Freney J.; Dumontet C.; Boumendjel A.; 3-Aryl-4-methyl-2-quinolones targeting multiresistant Staphylococcus aureus bacteria. ChemMedChem 2013,8(4),652-657","journal-title":"ChemMedChem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1021\/jm200370y","volume":"54","author":"Sabatini S.","year":"2011","unstructured":"Sabatini S.; Gosetto F.; Manfroni G.; Tabarrini O.; Kaatz G.W.; Patel D.; Cecchetti V.; Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. J Med Chem 2011,54(16),5722-5736","journal-title":"J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1021\/jm400262a","volume":"56","author":"Sabatini S.","year":"2013","unstructured":"Sabatini S.; Gosetto F.; Iraci N.; Barreca M.L.; Massari S.; Sancineto L.; Manfroni G.; Tabarrini O.; Dimovska M.; Kaatz G.W.; Cecchetti V.; Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance. J Med Chem 2013,56(12),4975-4989","journal-title":"J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"37007","DOI":"10.1039\/C7RA03859C","volume":"7","author":"Sabatini S.","year":"2017","unstructured":"Sabatini S.; Piccioni M.; Felicetti T.; De Marco S.; Manfroni G.; Pagiotti R.; Nocchetti M.; Cecchetti V.; Pietrella D.; Investigation on the Effect of Known Potent: S. Aureus NorA Efflux Pump Inhibitors on the Staphylococcal Biofilm Formation. RSC Advances 2017,7,37007-37014","journal-title":"RSC Advances"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jpba.2016.07.003","volume":"129","author":"Carotti A.","year":"2016","unstructured":"Carotti A.; Ianni F.; Sabatini S.; Di Michele A.; Sardella R.; Kaatz G.W.; Lindner W.; Cecchetti V.; Natalini B.; The \u201cracemic approach\u201d in the evaluation of the enantiomeric NorA efflux pump inhibition activity of 2-phenylquinoline derivatives. J Pharm Biomed Anal 2016,129,182-189","journal-title":"J Pharm Biomed Anal"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1021\/acs.jmedchem.8b00791","volume":"61","author":"Felicetti T.","year":"2018","unstructured":"Felicetti T.; Cannalire R.; Pietrella D.; Latacz G.; Lubelska A.; Manfroni G.; Barreca M.L.; Massari S.; Tabarrini O.; Kie\u0107-Kononowicz K.; Schindler B.D.; Kaatz G.W.; Cecchetti V.; Sabatini S.; 2-Phenylquinoline s. aureus nora efflux pump inhibitors: evaluation of the importance of methoxy group introduction. J Med Chem 2018,61(17),7827-7848","journal-title":"J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ejmech.2018.06.013","volume":"155","author":"Felicetti T.","year":"2018","unstructured":"Felicetti T.; Cannalire R.; Nizi M.G.; Tabarrini O.; Massari S.; Barreca M.L.; Manfroni G.; Schindler B.D.; Cecchetti V.; Kaatz G.W.; Sabatini S.; Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position. Eur J Med Chem 2018,155,428-433","journal-title":"Eur J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1073\/pnas.030540597","volume":"97","author":"Stermitz F.R.","year":"2000","unstructured":"Stermitz F.R.; Lorenz P.; Tawara J.N.; Zenewicz L.A.; Lewis K.; Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5\u2032-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 2000,97(4),1433-1437","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1021\/np990639k","volume":"63","author":"Stermitz F.R.","year":"2000","unstructured":"Stermitz F.R.; Tawara-Matsuda J.; Lorenz P.; Mueller P.; Zenewicz L.; Lewis K.; 5\u2032-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus. J Nat Prod 2000,63(8),1146-1149","journal-title":"J Nat Prod"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1021\/jm0004190","volume":"44","author":"Guz N.R.","year":"2001","unstructured":"Guz N.R.; Stermitz F.R.; Johnson J.B.; Beeson T.D.; Willen S.; Hsiang J.; Lewis K.; Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships. J Med Chem 2001,44(2),261-268","journal-title":"J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1348-0421.2005.tb03732.x","volume":"49","author":"Fujita M.","year":"2005","unstructured":"Fujita M.; Shiota S.; Kuroda T.; Hatano T.; Yoshida T.; Mizushima T.; Tsuchiya T.; Remarkable synergies between baicalein and tetracycline, and baicalein and \u03b2-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 2005,49(4),391-396","journal-title":"Microbiol Immunol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jep.2011.06.039","volume":"137","author":"Chan B.C.L.","year":"2011","unstructured":"Chan B.C.L.; Ip M.; Lau C.B.S.; Lui S.L.; Jolivalt C.; Ganem-Elbaz C.; Litaudon M.; Reiner N.E.; Gong H.; See R.H.; Fung K.P.; Leung P.C.; Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J Ethnopharmacol 2011,137(1),767-773","journal-title":"J Ethnopharmacol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/ptr.2695","volume":"23","author":"Falc\u00e3o-Silva V.S.","year":"2009","unstructured":"Falc\u00e3o-Silva V.S.; Silva D.A.; Souza, Mde.F.; Siqueira-Junior, J.P. Modulation of drug resistance in Staphylococcus aureus by a kaempferol glycoside from Herissantia tiubae (Malvaceae). Phytother Res 2009,23(10),1367-1370","journal-title":"Phytother Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jac\/dks005","volume":"67","author":"Holler J.G.","year":"2012","unstructured":"Holler J.G.; Christensen S.B.; Slotved H.C.; Rasmussen H.B.; G\u00fazman A.; Olsen C.E.; Petersen B.; M\u00f8lgaard P.; Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees. J Antimicrob Chemother 2012,67(5),1138-1144","journal-title":"J Antimicrob Chemother"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1515\/biolog-2016-0073","volume":"71","author":"Randhawa H.K.","year":"2016","unstructured":"Randhawa H.K.; Hundal K.K.; Ahirrao P.N.; Jachak S.M.; Nandanwar H.S.; Efflux Pump Inhibitory Activity of Flavonoids Isolated from Alpinia Calcarata against Methicillin-Resistant Staphylococcus Aureus. Biol 2016,71,484-493","journal-title":"Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.fitote.2013.07.015","volume":"90","author":"Roy S.K.","year":"2013","unstructured":"Roy S.K.; Kumari N.; Pahwa S.; Agrahari U.C.; Bhutani K.K.; Jachak S.M.; Nandanwar H.; Nor A.; NorA efflux pump inhibitory activity of coumarins from Mesua ferrea. Fitoterapia 2013,90,140-150","journal-title":"Fitoterapia"},{"key":"ref=74","first-page":"827","volume":"18","author":"Wang D.","year":"2018","unstructured":"Wang D.; Xie K.; Zou D.; Meng M.; Xie M.; Inhibitory effects of silybin on the efflux pump of methicillin resistant Staphylococcus aureus. Mol Med Rep 2018,18(1),827-833","journal-title":"Mol Med Rep"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.lwt.2016.04.003","volume":"85","author":"Diniz-Silva H.T.","year":"2017","unstructured":"Diniz-Silva H.T.; Magnani M.; de Siqueira S.; de Souza E.L.; de Siqueira-J\u00fanior J.P.; Fruit flavonoids as modulators of norfloxacin resistance in staphylococcus aureus that overexpresses NorA. Lebensm Wiss Technol 2017,85,324-326","journal-title":"Lebensm Wiss Technol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1007\/s00044-012-0401-7","volume":"22","author":"Sharma P.","year":"2013","unstructured":"Sharma P.; Kumar S.; Ali F.; Anthal S.; Gupta V.K.; Khan I.A.; Singh S.; Sangwan P.L.; Suri K.A.; Gupta B.D.; Gupta D.K.; Dutt P.; Vishwakarma R.A.; Satti N.K.; Synthesis and biologic activities of some novel heterocyclic chalcone derivatives. Med Chem Res 2013,22,3969-3983","journal-title":"Med Chem Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00000441-197605000-00002","volume":"271","author":"Pfeifer H.J.","year":"1976","unstructured":"Pfeifer H.J.; Greenblatt D.K.; Koch-Wester J.; Clinical toxicity of reserpine in hospitalized patients: a report from the boston collaborative drug surveillance program. Am J Med Sci 1976,271(3),269-276","journal-title":"Am J Med Sci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/jac\/42.6.807","volume":"42","author":"Schmitz F.J.","year":"1998","unstructured":"Schmitz F.J.; Fluit A.C.; L\u00fcckefahr M.; Engler B.; Hofmann B.; Verhoef J.; Heinz H.P.; Hadding U.; Jones M.E.; The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 1998,42(6),807-810","journal-title":"J Antimicrob Chemother"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1021\/cb600238x","volume":"1","author":"Ball A.R.","year":"2006","unstructured":"Ball A.R.; Casadei G.; Samosorn S.; Bremner J.B.; Ausubel F.M.; Moy T.I.; Lewis K.; Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial. ACS Chem Biol 2006,1(9),594-600","journal-title":"ACS Chem Biol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bmc.2005.09.019","volume":"14","author":"Samosorn S.","year":"2006","unstructured":"Samosorn S.; Bremner J.B.; Ball A.; Lewis K.; Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors. Bioorg Med Chem 2006,14(3),857-865","journal-title":"Bioorg Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00894-008-0328-6","volume":"14","author":"Dai Y.","year":"2008","unstructured":"Dai Y.; Zhang X.; Zhang X.; Wang H.; Lu Z.; DFT and GA studies on the QSAR of 2-aryl-5-nitro-1H-indole derivatives as NorA efflux pump inhibitors. J Mol Model 2008,14(9),807-812","journal-title":"J Mol Model"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1016\/j.bmcl.2008.06.093","volume":"18","author":"Ambrus J.I.","year":"2008","unstructured":"Ambrus J.I.; Kelso M.J.; Bremner J.B.; Ball A.R.; Casadei G.; Lewis K.; Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus. Bioorg Med Chem Lett 2008,18(15),4294-4297","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1016\/j.bmc.2009.04.028","volume":"17","author":"Samosorn S.","year":"2009","unstructured":"Samosorn S.; Tanwirat B.; Muhamad N.; Casadei G.; Tomkiewicz D.; Lewis K.; Suksamrarn A.; Prammananan T.; Gornall K.C.; Beck J.L.; Bremner J.B.; Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg Med Chem 2009,17(11),3866-3872","journal-title":"Bioorg Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1128\/AAC.01715-09","volume":"54","author":"Tomkiewicz D.","year":"2010","unstructured":"Tomkiewicz D.; Casadei G.; Larkins-Ford J.; Moy T.I.; Garner J.; Bremner J.B.; Ausubel F.M.; Lewis K.; Kelso M.J.; Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the berberine and INF55 components. Antimicrob Agents Chemother 2010,54(8),3219-3224","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/cmdc.201400042","volume":"9","author":"Hequet A.","year":"2014","unstructured":"Hequet A.; Burchak O.N.; Jeanty M.; Guinchard X.; Le Pihive E.; Maigre L.; Bouhours P.; Schneider D.; Maurin M.; Paris J.M.; Denis J.N.; Jolivalt C.; 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors. ChemMedChem 2014,9(7),1534-1545","journal-title":"ChemMedChem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/jac\/dkv015","volume":"70","author":"Caspar Y.","year":"2015","unstructured":"Caspar Y.; Jeanty M.; Blu J.; Burchak O.; Le Pihive E.; Maigre L.; Schneider D.; Jolivalt C.; Paris J.M.; Hequet A.; Minassian F.; Denis J.N.; Maurin M.; Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains. J Antimicrob Chemother 2015,70(6),1727-1737","journal-title":"J Antimicrob Chemother"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1021\/acs.jmedchem.5b01219","volume":"59","author":"Lepri S.","year":"2016","unstructured":"Lepri S.; Buonerba F.; Goracci L.; Velilla I.; Ruzziconi R.; Schindler B.D.; Seo S.M.; Kaatz G.W.; Cruciani G.; Indole based weapons to fight antibiotic resistance: a structure-activity relationship study. J Med Chem 2016,59(3),867-891","journal-title":"J Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1021\/acs.jmedchem.6b01281","volume":"60","author":"Buonerba F.","year":"2017","unstructured":"Buonerba F.; Lepri S.; Goracci L.; Schindler B.D.; Seo S.M.; Kaatz G.W.; Cruciani G.; Improved potency of indole-based nora efflux pump inhibitors: from serendipity toward rational design and development. J Med Chem 2017,60(1),517-523","journal-title":"J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.ejmech.2018.03.028","volume":"150","author":"Radix S.","year":"2018","unstructured":"Radix S.; Jordheim A.D.; Rocheblave L.; N\u2019Digo S.; Prignon A.L.; Commun C.; Michalet S.; Dijoux-Franca M.G.; Mularoni A.; Walchshofer N.N.; N\u2032-disubstituted cinnamamide derivatives potentiate ciprofloxacin activity against overexpressing NorA efflux pump Staphylococcus aureus 1199B strains. Eur J Med Chem 2018,150,900-907","journal-title":"Eur J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bmc.2018.12.008","volume":"27","author":"Rath S.K.","year":"2019","unstructured":"Rath S.K.; Singh S.; Kumar S.; Wani N.A.; Rai R.; Koul S.; Khan I.A.; Sangwan P.L.; Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus. Bioorg Med Chem 2019,27(2),343-353","journal-title":"Bioorg Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1021\/ja0288338","volume":"125","author":"Morandi F.","year":"2003","unstructured":"Morandi F.; Caselli E.; Morandi S.; Focia P.J.; Bl\u00e1zquez J.; Shoichet B.K.; Prati F.; Nanomolar inhibitors of AmpC \u03b2-lactamase. J Am Chem Soc 2003,125(3),685-695","journal-title":"J Am Chem Soc"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/jac\/dkt118","volume":"68","author":"Livermore D.M.","year":"2013","unstructured":"Livermore D.M.; Mushtaq S.; Activity of biapenem (RPX2003) combined with the boronate \u03b2-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae. J Antimicrob Chemother 2013,68(8),1825-1831","journal-title":"J Antimicrob Chemother"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1021\/jm401808n","volume":"57","author":"Fontaine F.","year":"2014","unstructured":"Fontaine F.; Hequet A.; Voisin-Chiret A.S.; Bouillon A.; Lesnard A.; Cresteil T.; Jolivalt C.; Rault S.; First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump. J Med Chem 2014,57(6),2536-2548","journal-title":"J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2015.02.056","volume":"95","author":"Fontaine F.","year":"2015","unstructured":"Fontaine F.; H\u00e9quet A.; Voisin-Chiret A.S.; Bouillon A.; Lesnard A.; Cresteil T.; Jolivalt C.; Rault S.; Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives. Eur J Med Chem 2015,95,185-198","journal-title":"Eur J Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.phytochem.2005.06.008","volume":"66","author":"Marquez B.","year":"2005","unstructured":"Marquez B.; Neuville L.; Moreau N.J.; Genet J.P.; dos Santos A.F.; Ca\u00f1o de Andrade M.C.; Sant\u2019Ana A.E.G.; Multidrug resistance reversal agent from Jatropha elliptica. Phytochemistry 2005,66(15),1804-1811","journal-title":"Phytochemistry"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1128\/AAC.50.2.810-812.2006","volume":"50","author":"Khan I.A.","year":"2006","unstructured":"Khan I.A.; Mirza Z.M.; Kumar A.; Verma V.; Qazi G.N.; Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 2006,50(2),810-812","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00284-009-9416-9","volume":"59","author":"Mohtar M.","year":"2009","unstructured":"Mohtar M.; Johari S.A.; Li A.R.; Isa M.M.; Mustafa S.; Ali A.M.; Basri D.F.; Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA). Curr Microbiol 2009,59(2),181-186","journal-title":"Curr Microbiol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/jac\/dkn088","volume":"61","author":"Kumar A.","year":"2008","unstructured":"Kumar A.; Khan I.A.; Koul S.; Koul J.L.; Taneja S.C.; Ali I.; Ali F.; Sharma S.; Mirza Z.M.; Kumar M.; Sangwan P.L.; Gupta P.; Thota N.; Qazi G.N.; Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother 2008,61(6),1270-1276","journal-title":"J Antimicrob Chemother"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"9847","DOI":"10.1016\/j.bmc.2008.09.042","volume":"16","author":"Sangwan P.L.","year":"2008","unstructured":"Sangwan P.L.; Koul J.L.; Koul S.; Reddy M.V.; Thota N.; Khan I.A.; Kumar A.; Kalia N.P.; Qazi G.N.; Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors. Bioorg Med Chem 2008,16(22),9847-9857","journal-title":"Bioorg Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1016\/j.bmcl.2016.07.062","volume":"26","author":"Wani N.A.","year":"2016","unstructured":"Wani N.A.; Singh S.; Farooq S.; Shankar S.; Koul S.; Khan I.A.; Rai R.; Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus. Bioorg Med Chem Lett 2016,26(17),4174-4178","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1039\/C5OB00246J","volume":"13","author":"Bharate J.B.","year":"2015","unstructured":"Bharate J.B.; Singh S.; Wani A.; Sharma S.; Joshi P.; Khan I.A.; Kumar A.; Vishwakarma R.A.; Bharate S.B.; Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump. Org Biomol Chem 2015,13(19),5424-5431","journal-title":"Org Biomol Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1128\/AAC.01306-05","volume":"51","author":"Vidaillac C.","year":"2007","unstructured":"Vidaillac C.; Guillon J.; Arpin C.; Forfar-Bares I.; Ba B.B.; Grellet J.; Moreau S.; Caignard D.H.; Jarry C.; Quentin C.; Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus. Antimicrob Agents Chemother 2007,51(3),831-838","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.1016\/j.bmc.2008.05.030","volume":"16","author":"Thota N.","year":"2008","unstructured":"Thota N.; Koul S.; Reddy M.V.; Sangwan P.L.; Khan I.A.; Kumar A.; Raja A.F.; Andotra S.S.; Qazi G.N.; Citral derived amides as potent bacterial NorA efflux pump inhibitors. Bioorg Med Chem 2008,16(13),6535-6543","journal-title":"Bioorg Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1016\/j.ejmech.2010.05.006","volume":"45","author":"Thota N.","year":"2010","unstructured":"Thota N.; Reddy M.V.; Kumar A.; Khan I.A.; Sangwan P.L.; Kalia N.P.; Koul J.L.; Koul S.; Substituted dihydronaphthalenes as efflux pump inhibitors of Staphylococcus aureus. Eur J Med Chem 2010,45(9),3607-3616","journal-title":"Eur J Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.micpath.2018.08.022","volume":"124","author":"Sundaramoorthy N.S.","year":"2018","unstructured":"Sundaramoorthy N.S.; Mitra K.; Ganesh J.S.; Makala H.; Lotha R.; Bhanuvalli S.R.; Ulaganathan V.; Tiru V.; Sivasubramanian A.; Nagarajan S.; Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo. Microb Pathog 2018,124,54-62","journal-title":"Microb Pathog"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3389\/fmicb.2019.02762","volume":"10","author":"Zimmermann S.","year":"2019","unstructured":"Zimmermann S.; Klinger-Strobel M.; Bohnert J.A.; Wendler S.; R\u00f6del J.; Pletz M.W.; L\u00f6ffler B.; Tuchscherr L.; Clinically approved drugs inhibit the staphylococcus aureus multidrug nora efflux pump and reduce biofilm formation. Front Microbiol 2019,10,2762","journal-title":"Front Microbiol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1128\/AAC.47.2.719-726.2003","volume":"47","author":"Kaatz G.W.","year":"2003","unstructured":"Kaatz G.W.; Moudgal V.V.; Seo S.M.; Kristiansen J.E.; Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2003,47(2),719-726","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1021\/jm701623q","volume":"51","author":"Sabatini S.","year":"2008","unstructured":"Sabatini S.; Kaatz G.W.; Rossolini G.M.; Brandini D.; Fravolini A.; From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. J Med Chem 2008,51(14),4321-4330","journal-title":"J Med Chem"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1016\/j.bmc.2007.04.023","volume":"15","year":"2007","unstructured":"Fournier dit Chabert, J.; Marquez, B.; Neville, L.; Joucla, L.; Broussous, S.; Bouhours, P.; David, E.; Pellet-Rostaing, S.; Marquet, B.; Moreau, N.; Lemaire, M. Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the nora multidrug transporter of staphylococcus aureus. Bioorg Med Chem 2007,15,4482-4497","journal-title":"Bioorg Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/cmdc.201500463","volume":"11","author":"Liger F.","year":"2016","unstructured":"Liger F.; Bouhours P.; Ganem-Elbaz C.; Jolivalt C.; Pellet-Rostaing S.; Popowycz F.; Paris J.M.; Lemaire M.; C2 Arylated benzo[b]thiophene derivatives as staphylococcus aureus nora efflux pump inhibitors. ChemMedChem 2016,11(3),320-330","journal-title":"ChemMedChem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1007\/s00253-016-7759-2","volume":"100","author":"Lowrence R.C.","year":"2016","unstructured":"Lowrence R.C.; Raman T.; Makala H.V.; Ulaganathan V.; Subramaniapillai S.G.; Kuppuswamy A.A.; Mani A.; Chittoor Neelakantan S.; Nagarajan S.; Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model. Appl Microbiol Biotechnol 2016,100(21),9265-9281","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1016\/j.bmc.2019.07.006","volume":"27","author":"Pereira P.S.","year":"2019","unstructured":"Pereira P.S.; Lima M.D.C.A.; Neto P.P.M.; Oliveira-Tintino C.D.M.; Tintino S.R.; Menezes I.R.A.; de Oliveira J.F.; Marchand P.; Coutinho H.D.M.; Rodrigues M.D.D.; da Silva T.G.; Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains. Bioorg Med Chem 2019,27(17),3797-3804","journal-title":"Bioorg Med Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1021\/jm1011963","volume":"54","author":"Brincat J.P.","year":"2011","unstructured":"Brincat J.P.; Carosati E.; Sabatini S.; Manfroni G.; Fravolini A.; Raygada J.L.; Patel D.; Kaatz G.W.; Cruciani G.; Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. J Med Chem 2011,54(1),354-365","journal-title":"J Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/AAC.00735-10","volume":"55","author":"Kalle A.M.","year":"2011","unstructured":"Kalle A.M.; Rizvi A.; Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob Agents Chemother 2011,55(1),439-442","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1055\/s-2004-835860","volume":"70","author":"Gibbons S.","year":"2004","unstructured":"Gibbons S.; Moser E.; Kaatz G.W.; Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Med 2004,70(12),1240-1242","journal-title":"Planta Med"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/jac\/42.2.211","volume":"42","author":"Yam T.S.","year":"1998","unstructured":"Yam T.S.; Hamilton-Miller J.M.T.; Shah S.; The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2\u2032 synthesis, and beta-lactamase production in Staphylococcus aureus. J Antimicrob Chemother 1998,42(2),211-216","journal-title":"J Antimicrob Chemother"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/jac\/46.5.852","volume":"46","author":"Hamilton-Miller J.M.T.","year":"2000","unstructured":"Hamilton-Miller J.M.T.; Shah S.; Activity of the tea component epicatechin gallate and analogues against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2000,46(5),852-853","journal-title":"J Antimicrob Chemother"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1574-6968.1999.tb13698.x","volume":"176","author":"Hamilton-Miller J.M.T.","year":"1999","unstructured":"Hamilton-Miller J.M.T.; Shah S.; Disorganization of cell division of methicillin-resistant Staphylococcus aureus by a component of tea (Camellia sinensis): a study by electron microscopy. FEMS Microbiol Lett 1999,176(2),463-469","journal-title":"FEMS Microbiol Lett"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1021\/np030409c","volume":"67","author":"Belofsky G.","year":"2004","unstructured":"Belofsky G.; Percivill D.; Lewis K.; Tegos G.P.; Ekart J.; Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J Nat Prod 2004,67(3),481-484","journal-title":"J Nat Prod"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.bmcl.2006.12.059","volume":"17","author":"Michalet S.","year":"2007","unstructured":"Michalet S.; Cartier G.; David B.; Mariotte A.M.; Dijoux-franca M.G.; Kaatz G.W.; Stavri M.; Gibbons S.; N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. Bioorg Med Chem Lett 2007,17(6),1755-1758","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ijantimicag.2013.08.007","volume":"42","author":"Shiu W.K.P.","year":"2013","unstructured":"Shiu W.K.P.; Malkinson J.P.; Rahman M.M.; Curry J.; Stapleton P.; Gunaratnam M.; Neidle S.; Mushtaq S.; Warner M.; Livermore D.M.; Evangelopoulos D.; Basavannacharya C.; Bhakta S.; Schindler B.D.; Seo S.M.; Coleman D.; Kaatz G.W.; Gibbons S.; A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus. Int J Antimicrob Agents 2013,42(6),513-518","journal-title":"Int J Antimicrob Agents"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.micpath.2016.04.003","volume":"97","author":"Tintino S.R.","year":"2016","unstructured":"Tintino S.R.; Oliveira-Tintino C.D.M.; Campina F.F.; Silva R.L.P.; Costa, Mdo.S.; Menezes, I.R.; Calixto-J\u00fanior, J.T.; Siqueira-Junior, J.P.; Coutinho, H.D.; Leal-Balbino, T.C.; Balbino, V.Q. Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus. Microb Pathog 2016,97,9-13","journal-title":"Microb Pathog"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/bkcs.10901","volume":"37","author":"Park K.S.","year":"2016","unstructured":"Park K.S.; Choo H.; Kim M.K.; Chong Y.; Quercetin 7-O-Glutamate Potentiates Staphylococcus Aureus to Fluoroquinolone Antibiotics. Bull Korean Chem Soc 2016,37,1515-1517","journal-title":"Bull Korean Chem Soc"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3389\/fmicb.2017.01868","volume":"8","author":"Singh S.","year":"2017","unstructured":"Singh S.; Kalia N.P.; Joshi P.; Kumar A.; Sharma P.R.; Kumar A.; Bharate S.B.; Khan I.A.; Boeravinone B.; Boeravinone B, a novel dual inhibitor of nora bacterial efflux pump of staphylococcus aureus and human p-glycoprotein, reduces the biofilm formation and intracellular invasion of bacteria. Front Microbiol 2017,8,1868","journal-title":"Front Microbiol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cimid.2018.03.001","volume":"57","author":"Dos Santos J.F.S.","year":"2018","unstructured":"Dos Santos J.F.S.; Tintino S.R.; de Freitas T.S.; Campina F.F.; de A Menezes, I.R.; Siqueira-J\u00fanior, J.P.; Coutinho, H.D.M.; Cunha, F.A.B. In vitro e in silico evaluation of the inhibition of Staphylococcus aureus efflux pumps by caffeic and gallic acid. Comp Immunol Microbiol Infect Dis 2018,57,22-28","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1128\/AAC.00216-07","volume":"51","author":"Smith E.C.J.","year":"2007","unstructured":"Smith E.C.J.; Kaatz G.W.; Seo S.M.; Wareham N.; Williamson E.M.; Gibbons S.; The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 2007,51(12),4480-4483","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.micpath.2016.08.026","volume":"99","author":"Co\u00ealho M.L.","year":"2016","unstructured":"Co\u00ealho M.L.; Ferreira J.H.L.; de Siqueira J\u00fanior J.P.; Kaatz G.W.; Barreto H.M.; de Carvalho Melo Cavalcante A.A.; Inhibition of the NorA multi-drug transporter by oxygenated monoterpenes. Microb Pathog 2016,99,173-177","journal-title":"Microb Pathog"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/s00044-019-02375-9","volume":"28","author":"Sun Z.L.","year":"2019","unstructured":"Sun Z.L.; Liu T.; Gibbons S.; Mu Q.; A Structure-Activity Relationship Study of Phenyl Sesquiterpenoids on Efflux Inhibition against Staphylococcus Aureus. Med Chem Res 2019,28,1308-1318","journal-title":"Med Chem Res"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ffj.1584","volume":"20","author":"C\u00e9gi\u00e9la-Carlioz P.","year":"2005","unstructured":"C\u00e9gi\u00e9la-Carlioz P.; Bessi\u00e8re J.M.; David B.; Mariotte A.M.; Gibbons S.; Dijoux-Franca M.G.; Modulation of multi-drug resistance (mdr) in staphylococcus aureus by osha (ligusticum porteri l., apiaceae) essential oil compounds. Flavour Fragrance J 2005,20,671-675","journal-title":"Flavour Fragrance J"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.foodchem.2018.04.040","volume":"262","author":"de Morais Oliveira-Tintino C.D.","year":"2018","unstructured":"de Morais Oliveira-Tintino C.D.; Tintino S.R.; Limaverde P.W.; Figueredo F.G.; Campina F.F.; da Cunha F.A.B.; da Costa R.H.S.; Pereira P.S.; Lima L.F.; de Matos Y.M.L.S.; Coutinho H.D.M.; Siqueira-J\u00fanior J.P.; Balbino V.Q.; da Silva T.G.; Inhibition of the essential oil from Chenopodium ambrosioides L. and \u03b1-terpinene on the NorA efflux-pump of Staphylococcus aureus. Food Chem 2018,262,72-77","journal-title":"Food Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/lam.13163","volume":"69","author":"Silva S.W.C.","year":"2019","unstructured":"Silva S.W.C.; Mon\u00e7\u00e3o N.B.N.; Ara\u00fajo B.Q.; Arcanjo D.D.R.; Ferreira J.H.L.; Lima Neto J.S.; Cit\u00f3 A.M.G.L.; de Siqueira J\u00fanior J.P.; Kaatz G.W.; Barreto H.M.; Antimicrobial activity of Mimosa caesalpiniifolia Benth and its interaction with antibiotics against Staphylococcus aureus strains overexpressing efflux pump genes. Lett Appl Microbiol 2019,69(1),57-63","journal-title":"Lett Appl Microbiol"},{"key":"ref=132","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103935","volume":"140","author":"de Sousa Andrade L.M.","year":"2020","unstructured":"de Sousa Andrade L.M.; de Oliveira A.B.M.; Leal A.L.A.B.; de Alc\u00e2ntara Oliveira F.A.; Portela A.L.; de Sousa Lima Neto J.; de Siqueira-J\u00fanior J.P.; Kaatz G.W.; da Rocha C.Q.; Barreto H.M.; Antimicrobial activity and inhibition of the NorA efflux pump of Staphylococcus aureus by extract and isolated compounds from Arrabidaea brachypoda. Microb Pathog 2020,140","journal-title":"Microb Pathog"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.micpath.2019.03.012","volume":"130","author":"Braga Ribeiro A.M.","year":"2019","unstructured":"Braga Ribeiro A.M.; Sousa J.N.; Costa L.M.; Oliveira F.A.A.; Dos Santos R.C.; Silva Nunes A.S.; da Silva W.O.; Marques Cordeiro P.J.; de Sousa Lima Neto J.; de Siqueira-J\u00fanior J.P.; Kaatz G.W.; Barreto H.M.; de Oliveira A.P.; Antimicrobial activity of Phyllanthus amarus Schumach.","journal-title":"Microb Pathog"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/np050227d","volume":"69","author":"Pereda-Miranda R.","year":"2006","unstructured":"Pereda-Miranda R.; Kaatz G.W.; Gibbons S.; Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus. J Nat Prod 2006,69(3),406-409","journal-title":"J Nat Prod"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1021\/np800148w","volume":"71","author":"Ch\u00e9rigo L.","year":"2008","unstructured":"Ch\u00e9rigo L.; Pereda-Miranda R.; Fragoso-Serrano M.; Jacobo-Herrera N.; Kaatz G.W.; Gibbons S.; Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides. J Nat Prod 2008,71(6),1037-1045","journal-title":"J Nat Prod"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.phytochem.2008.12.005","volume":"70","author":"Ch\u00e9rigo L.","year":"2009","unstructured":"Ch\u00e9rigo L.; Pereda-Miranda R.; Gibbons S.; Bacterial resistance modifying tetrasaccharide agents from Ipomoea murucoides. Phytochemistry 2009,70(2),222-227","journal-title":"Phytochemistry"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejphar.2014.07.020","volume":"740","author":"Zhang J.","year":"2014","unstructured":"Zhang J.; Sun Y.; Wang Y.; Lu M.; He J.; Liu J.; Chen Q.; Zhang X.; Zhou F.; Wang G.; Sun X.; Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor. Eur J Pharmacol 2014,740,277-284","journal-title":"Eur J Pharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/j.phytochem.2004.08.044","volume":"65","author":"Abulrob A.N.","year":"2004","unstructured":"Abulrob A.N.; Suller M.T.E.; Gumbleton M.; Simons C.; Russell A.D.; Identification and biological evaluation of grapefruit oil components as potential novel efflux pump modulators in methicillin-resistant Staphylococcus aureus bacterial strains. Phytochemistry 2004,65(22),3021-3027","journal-title":"Phytochemistry"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/cmdc.201700286","volume":"12","author":"Felicetti T.","year":"2017","unstructured":"Felicetti T.; Cannalire R.; Burali M.S.; Massari S.; Manfroni G.; Barreca M.L.; Tabarrini O.; Schindler B.D.; Sabatini S.; Kaatz G.W.; Cecchetti V.; Searching for novel inhibitors of the S. aureus NorA efflux pump: synthesis and biological evaluation of the 3-phenyl-1,4-benzothiazine analogues. ChemMedChem 2017,12(16),1293-1302","journal-title":"ChemMedChem"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183461","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183461\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T09:23:04Z","timestamp":1617441784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183461\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":139,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,11,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026620666200704135837","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}